The apolipoprotein E2 isoform is associated with accelerated onset of Coronary Artery Disease in Systemic Lupus Erythematosus

Medical Science Monitor

Volumn 14, Issue 5, 2008, Pages

  Orlacchio, Antonio ^a,b   Bruce, Ian N ^c,d   Rahman, Proton ^c,e   Kawarai, Toshitaka ^f   Bernardi, Giorgio ^a,b   St George Hyslop, Peter H ^g,h   Gladman, Dafna D ^c   Urowitz, Murray B ^c  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^f Hyogo Brain and Heart Center ^*  (Japan)

^g UNIVERSITY OF TORONTO   (Canada)

^h TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Apolipoprotein E; Coronary artery disease; Systemic lupus erythematosus

Indexed keywords

APOLIPOPROTEIN E2; CHOLESTEROL; CREATINE KINASE MB;

ADULT; ANGINA PECTORIS; ARTICLE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; ALLELES; APOLIPOPROTEIN E2; CHOLESTEROL; CORONARY ARTERY DISEASE; FEMALE; GENE EXPRESSION REGULATION; HAPLOTYPES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROGNOSIS; PROTEIN ISOFORMS;

EID: 43549125772     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Gladman DD, Goldsmith CH, Urowitz MB et al: The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol, 2000; 27: 373-76
2. Bruce IN, Gladman DD, Urowitz MB et al: The natural history of hypercholesterolaemia in SLE. J Rheumatol, 1999; 26: 2137-43
3. National Institute of Aging/Alzheimer's Association Working Group: Apolipoprotein E genotyping in Alzheimer's disease. Lancet, 1996; 347: 1091-95
4. Wilson PWF, Myers RH, Larson MG et al: Apolipoprotein E alleles, dyslipidemia and coronary heart disease. The Framingham Offspring Study. JAMA, 1994; 272: 1666-71
5. Van Bockxmeer FM, Mamotte CD: Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease. Lancet, 1992; 340: 879-80
6. Eichner JE, Kuller LH, Orchard TJ et al: Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol, 1993; 71: 160-65
7. Moore JH, Reilly SL, Ferrell RE, Sing CF: The role of apolipoprotien E polymorphism in the prediction of coronary artery disease age of onset. Clin Genet, 1997; 51: 22-25
8. Gazioglu NM, Erensoy N, Kadioglu P et al: Altered cyclin D1 genotype distribution in human sporadic pituitary adenomas. Med Sci Monit, 2007; 13(10): CR457-63
9. Hixson JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res, 1990; 31: 545-48
10. Orlacchio A, Kawarai T, Polidoro M et al: Lack of association between Alzheimer's disease and the promoter region polymorphisms of the nicastrin gene. Neurosci Lett, 2004; 363: 49-53
11. Salobir B, Medica I, Tercelj M et al: Association of angiotensin- converting enzyme/DD genotype with sarcoidosis susceptibility in Slovenian patients. Med Sci Monit, 2007; 13(12): CR538-42
12. Harley JB, Moser KL, Gaffney PM, Behrens TW: The genetics of human systemic lupus erythematosus. Curr Opin Immunol, 1998; 10: 690-96
13. Moser KL, Neas BR, Salmon JE et al: Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci USA, 1998; 95: 14869-74
14. Gaffney PM, Kearns GM, Shark KB et al: A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc Natl Acad Sci USA, 1998; 95: 14875-79
15. Shai R, Quismorio FP, Li L et al: Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum Mol Genet, 1999; 8: 639-44
16. Ghosh S, Collins FS: The geneticist's approach to complex disease. Ann Rev Med, 1996; 47: 333-53
17. Schupf N, Kapell D, Lee JH et al: Onset of dementia is associated with apolipoprotein E episilon 4 in Down's syndrome. Ann Neurol, 1996; 40: 799-801
18. Del Bo R, Comi GP, Bresolin N et al: The apolipoprotien E epsilon 4 allele causes a faster decline of cognitive performances in Down's syndrome subjects. J Neurol Sci, 1997; 145: 87-91
19. Prasher VP, Chowdhury TA, Rowe BR, Bain SC: Apo E genotype and Alzheimer's disease in adults with Down syndrome: meta-analysis. Am J Ment Retard, 1997; 102: 103-10
20. Mooser V, Helbecque N, Miklossy J et al: Interactions between apolipoprotein E and apolipoprotien (a) in patients with late-onset Alzheimer disease. Ann Intern Med, 2000; 132: 533-37
21. Borba EF, Bonfa E: Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity and anticardiolipin antibodies. Lupus, 1997; 6: 533-39
22. Ettinger WH, Goldberg AP, Applebaum-Bowden D et al: Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids. Am J Med, 1987; 83: 503-8